Results 71 to 80 of about 40,236 (221)
Clinical implications of imlifidase interference in antibody screening and transfusion management
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani +2 more
wiley +1 more source
Guillain-Barre Syndrome: Age Variations
The medical records of 83 children with Guillain-Barre Syndrome were reviewed with reference to the age associated changes at the Department of Pediatrics, University of Tokyo ...
J Gordon Millichap
core +1 more source
Governance of Long‐Term Scientific Infrastructure: Public Value Does Not Protect Itself
Abstract Long‐term scientific infrastructure, including physical archives, monitoring networks, and place‐based research facilities, is frequently described as important but is rarely protected by enforceable governance. When administrative reorganization or budget pressure threatens such infrastructure, the scientific community typically responds with
A. Veltri
wiley +1 more source
Ultrasound‐Confirmed Median Nerve Pseudoconduction Block due to Anatomical Variation
ABSTRACT Introduction/Aims Conduction block (CB) at non‐entrapment sites is an important electrodiagnostic (EDX) feature supporting acquired demyelinating neuropathies. However, anatomical variation may produce pseudoconduction block, mimicking true CB.
Yajing Ye +2 more
wiley +1 more source
The association between Campylobacter infection and subsequent Guillain-Barre syndrome (GBS) has been well documented. To date, however, there exists no direct estimate of the incidence of GBS among patients with Campylobacter infection.
Tam, CC +11 more
core
Guillain-Barre syndrome is an acute inflammatory demyelinating polyradiculoneuropathy of autoimmune etiology, which is characterized by peripheral paralysis and protein-cell dissociation in the cerebrospinal fluid in most cases. The Guillain-Barre syndrome prevalence is 0.6-2.4 cases per 100 thousand population.
D E Kutepov, N I Litvinov
openaire +2 more sources
Vectors and Vector‐Borne Diseases: Biology, Epidemiology and Integrated Control Strategies
ABSTRACT Vector‐Borne Diseases (VBDs), transmitted by arthropods such as mosquitoes, ticks, fleas and sandflies, represent a significant threat to global health. These diseases can be caused by a variety of pathogens, including bacteria, viruses, protozoa, and helminths.
Roberta Rinaldi +4 more
wiley +1 more source
Guillain-Barré syndrome is a rare condition that can be potentially life-threatening. Guillain-Barré syndrome does not have a definitive etiological agent.
Sakif Ahamed Khan +3 more
doaj +1 more source
Case report: Guillain-Barre syndrome with pneumococcus – A new association in pediatrics
Guillain-Barre Syndrome, an acute flaccid paralysis known to be caused by recent Gastro-intestinal infections mainly campylobacter, and Respiratory infections mainly mycoplasma pneumoniae and influenza.
Hassan El Khatib +4 more
doaj +1 more source

